Idamakanti M, Bijjam RI, Kumar M, Mukkamalla SK. Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review. J Med Cases. 2025;16(6):212-221. doi:10.14740/jmc5136